Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study. uri icon

Overview

publication date

  • October 1, 2021

Research

keywords

  • Benzamides
  • Lymphoma, Large B-Cell, Diffuse

Identity

PubMed Central ID

  • PMC8485664

Scopus Document Identifier

  • 85116207263

Digital Object Identifier (DOI)

  • 10.3324/haematol.2021.278654

PubMed ID

  • 34233448

Additional Document Info

volume

  • 106

issue

  • 10